StatSure Diagnostic Systems, Inc. (SSUR) Research

StatSure Diagnostic Systems, Inc. specializes in the creation, production, and distribution of swift in-vitro diagnostic tests. These assays are utilized for identifying infectious diseases and a range of other health concerns, with their availability spanning both the United States and global markets. Among its key offerings are the SURE CHECK HIV 1/2 and Clearview Complete HIV 1/2 tests, which are singular-use diagnostic tools crafted for the visual detection of antibodies to HIV-1 and HIV-2. The company also supplies equipment for collecting medical specimens. Established in 1986, the firm maintains its headquarters in Brooklyn, New York.

Market snapshot

Symbol
SSUR
Price
$0.00
Day change
-99.60%
Market cap
$107.1K
52-week range
2.0E-4-2.0E-4
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Cell Kinetics Ltd. (CKNTF)
  • Miravant Medical Technologies Inc. (MRVT)
  • Invitae Corporation (NVTAQ)
  • Nexeon MedSystems Inc. (NXNN)
  • PotNetwork Holdings, Inc. (POTN)
  • Predictive Technology Group, Inc. (PRED)
  • QuantRx Biomedical Corporation (QTXB)
  • RedHawk Holdings Corp. (SNDD)

Open StatSure Diagnostic Systems, Inc. (SSUR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.